DHT Holdings Inc (NYSE: DHT)
$6.30 −0.020 (0.32%)
DHT is an independent crude oil tanker company. Our fleet trades internationally and consists of crude oil tankers in the VLCC segment. Low global oil demand, combined with global oil oversupply, has dragged down the oil price significantly. The oil storage demand surges, leading to much higher storage spot rates. Many oil tanker businesses will benefit from this trend. DHT, with long-term fixed-rate contracts, would lead to its earnings stability during the contract durations. It could be worth $16 per share.
IZEA Worldwide Inc (NASDAQ: IZEA)
$0.65 +0.023 (3.68%)
IZEA Worldwide, Inc. operates as an online media marketing company. The Company develops a technology that helps creators to earn money for producing and distributing content for marketers. IZEA Worldwide serves customers worldwide.
ROTH Capital has made an estimate for IZEA Worldwide Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 03, 2016.
The Average True Range (ATR) for IZEA Worldwide Inc. is set at 0.09, with the Price to Sales ratio for IZEA stock in the period of the last 12 months amounting to 1.19. The Price to Book ratio for the last quarter was 1.58, with the Price to Cash per share for the same quarter was set at 0.17.
Sorrento Therapeutics Inc (NASDAQ:SRNE)
$6.76 USD +4.14 (158.02%)
Sorrento Therapeutics Inc. SRNE, +158.01% blasted 153% higher on very heavy volume in afternoon trading Friday, putting it on track to close at a near 2-year high, after the biopharmaceutical company provided an upbeat assessment of the results of a preclinical experiment of its COVID-19 virus antibody. Trading volume exploded to 364.8 million shares, enough to make the stock the most actively traded on major U.S. exchanges, and well above the full-day average of about 6.6 million shares. After four days of incubation, Sorrento said it STI-1499 antibody demonstrated 100% inhibition of the COVID-19 virus infection of healthy cells.
Kitov Pharma (NASDAQ:KTOV)
$0.53 +0.042 (8.55%)
Kitov to Present Phase 1 Data on CM-24 in Patients with Advanced Cancer at American Society of Clinical Oncology 2020 Virtual Scientific Program
A clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the positive results of a previously reported Phase 1 trial of CM-24, a monoclonal antibody targeting CEACAM1, a novel immune checkpoint that supports tumor immune evasion and survival through multiple pathways, in patients with advanced cancer will be presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual
Aurora Cannabis Inc (TSE:ACB)
$15.35 CAD +6.15 (66.85%)
Aurora Cannabis posted a smaller loss compared with the prior quarter as customers in the United States and Canada stockpiled cannabis ahead of lockdowns, sending its U.S.-listed shares up 13% after the bell on Thursday.
The Canadian pot producer sold 12,729 kilograms of cannabis in the third quarter, 39% more than a year earlier. The sales spike comes as cannabis is an essential service in several provinces and states across Canada and the Unites States.
Its reported quarter was the first full period of sales in its so-called cannabis 2.0 portfolio, which includes vapes, edible gummies, chocolates and beverages, products that customers rushed to stock up ahead of the Covid-19 lockdowns.